The firm, based in Cambridge, was established in the United States but has made numerous investments in France. It has a diverse portfolio of startups, including InFlectis BioScience and Mitoconix Bio. Remiges Ventures typically invests in startups that are 2-3 years old and participates in rounds with 3-4 other investors. While Vesalius Biocapital Partners, VC Fonds Technologie Berlin, and Lumira Ventures are common co-investors, the fund is also often supported by Vesalius Biocapital Partners, VC Fonds Technologie Berlin, and SICAR. Remiges Ventures is an active investor, with a focus on deals ranging from $10 to $50 million. The firm has a track record of successful exits and was particularly active in 2018.